You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6394]

  • In development
  • Reference number: GID-TA11452
  • Expected publication date:  23 October 2025
  • Project information
  • Project documents

On this page

  1. Draft guidance: 1
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6394
  4. Topic selection

Documents

Documents created during the development process.

Draft guidance: 1

  • Draft guidance: 1

  • Draft guidance (downloadable version) (PDF 275 KB)

    Published:
    02 July 2025
  • Draft guidance (online commenting)

  • Committee papers (PDF 9.33 MB)

    Published:
    02 July 2025
  • Public committee slides (PDF 996 KB)

    Published:
    02 July 2025
  • Equality impact assessment (downloadable version) (PDF 128 KB)

    Published:
    02 July 2025

Invitation to participate

  • Final scope (PDF 163 KB)

    Published:
    05 September 2024
  • Final stakeholder list (PDF 183 KB)

    Published:
    05 September 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 398 KB)

    Published:
    05 September 2024
  • Equality impact assessment (scoping) (PDF 130 KB)

    Published:
    05 September 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6394

  • Draft matrix post referral (PDF 179 KB)

    Published:
    28 June 2024
  • Draft scope post referral (PDF 171 KB)

    Published:
    28 June 2024

Topic selection

  • Topic selection

Back to top